Evidence map›Paper›PMID 41918725›Full record

Observational studyFrontiers in immunology2026

Prevalence and characteristics of coronary arteritis within a prospective observational cohort of patients with Takayasu's arteritis.

Safa Farrukh, Kaitlin A Quinn, Alessandra Brofferio, Kathleen Mitchell, W Patricia Bandettini, Bhanu Richa Duggirala, Michael Ring, Marcus Y Chen, Peter C Grayson

Abstract readObservational Study
In one paragraph

Observational study in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Safa FarrukhNational Institute of Arthritis and Musculoskeletal Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Kaitlin A QuinnNational Institute of Arthritis and Musculoskeletal Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.
Alessandra BrofferioNational Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, United States.
Kathleen MitchellNational Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, United States.
W Patricia BandettiniNational Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, United States.
Bhanu Richa DuggiralaBiomedical Translational Research Informatics (BTRIS), National Institutes of Health (NIH) Clinical Center, National Institutes of Health, Bethesda, MD, United States.
Michael RingBiomedical Translational Research Informatics (BTRIS), National Institutes of Health (NIH) Clinical Center, National Institutes of Health, Bethesda, MD, United States.
Marcus Y ChenNational Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, United States.
Peter C GraysonNational Institute of Arthritis and Musculoskeletal Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Due to the rarity of the condition, optimal assessment and therapeutic strategies to manage coronary arteritis in Takayasu's arteritis (TAK) have not been well defined. Methods: Cases of coronary arteritis were identified within an ongoing single-center prospective observational cohort study in TAK. Patients underwent standardized clinical, imaging, and laboratory assessment per protocol with centralized review of data. Imaging assessment included non-invasive angiography of the aorta and branch vessels, cardiac computed tomographic angiography, cardiovascular magnetic resonance imaging, and positron emission tomography (PET). Cardiac involvement was defined based on demonstration of at least one vasculitic lesion within a coronary artery by an appropriate imaging study. Results: The prevalence of coronary arteritis was 13 (9%) out of 137 patients with TAK. Patients with and without coronary arteritis were similar in terms of demographics, angiographic pattern of disease, and non-cardiac clinical symptoms. Vasculitic lesions typically were stenosing and involved the proximal coronary arteries. Active vasculitis by PET in the ascending aorta was associated with active coronary arteritis (sensitivity 100%, specificity 67%). Favorable clinical outcomes were generally achievable but often required medical therapy and vascular intervention. Anti-cytokine medical therapies were likely more effective than cytotoxic therapies. Fifty percent of patients had complications from vascular grafts or stents, respectively, often prompting additional vascular procedures. Discussion: Coronary arteritis is an uncommon complication in TAK. Multimodal imaging can be useful to diagnose, monitor, and manage coronary arteritis. While medical therapy is preferred, vascular intervention may be necessary, and complications from attempts at vascular reperfusion are common.

Indexed as

Coronary Artery DiseaseTakayasu ArteritisAdultComputed Tomography AngiographyCoronary AngiographyFemaleHumansMaleMiddle AgedPositron-Emission TomographyPrevalenceProspective Studiesangiographycomputed tomographycoronary arteryTakayasu’s arteritisvasculitis

Identifiers

PMID41918725
PMCPMC13033626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.